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Endografts with suprarenal fixation do not
perform better than those with infrarenal fixation
in the treatment of patients with short straight
proximal aortic necks
Eric S. Hager, MD,a Jae S. Cho, MD,a Michel S. Makaroun, MD,a Sun Cheol Park, MD,b
Rabih Chaer, MD,a Luke Marone, MD,a and Robert Y. Rhee, MD,a Pittsburgh, Pa; and Seoul, Korea
Objective: To determine if there are any differences in outcomes between infrarenal fixation (IF) and suprarenal fixation
(SF) endograft systems for the endovascular treatment (endovascular aneurysm repair [EVAR]) of abdominal aortic
aneurysms (AAAs) with short, straight proximal aortic necks (<1.5 cm).
Methods: A retrospective review of 1379 EVAR procedures was performed between the years of 2002 and 2009 at a single
institution. The charts and radiographic images of all patients were reviewed. Patients who underwent EVAR with AAA
morphology with short proximal necks were stratified into two groups: IF, Gore Excluder (W. L. Gore, Flagstaff, Ariz)
group and SF, Cook Zenith (Cook, Bloomington, Ind) group. The primary end point for the study was the presence of
proximal type 1 endoleaks. Secondary end points were graft migration at 1- and 2-year follow-up and aneurysm sac
regression. The groups’ demographics and comorbidities were also compared.
Results:A total of 1379 EVARSwere performed during the study period and 84were identified as having a short proximal
aortic neck. Sixty patients were in the IF group and 24 in the SF group. The average follow-up period was 18.6 months
(IF) and 18.5 months (SF). There was no difference in the average proximal neck length (1.19 cm IF vs 1.14 cm SF; P 
not significant [NS]) or the preoperative AAA size (5.8 cm IF vs 5.9 cm SF; PNS). There were no significant differences
in age (76.6 years IF vs 74.8 years SF; P  .32), gender (IF 66.7% vs SF 21.88% men; P  .053), or length of stay (2.2
days IF vs 1.9 days SF; P  .39). The comorbidities (diabetes, hypertension, and warfarin use) were also similar. There
were five type 1a endoleaks in group IF and one in group SF (P .44) identified at the 1-month follow-up; however, only
one patient in the IF group underwent intervention for enlargement of the AAA sac. At 1 year, there was persistence of
one type 1a endoleak in both groups, but these were deemed dead-end leaks as they did not fill the sac nor lead to
aneurysm growth. There were no migrations (>0.5 cm) noted in either group. Sac regression was observed at an average
rate of 0.24 cm/year in the IF group and 0.26 cm/year in the SF group (P  NS). There were no aneurysm ruptures
during the study period.
Conclusions: There are no significant differences in endograft migration or in the incidence of early and late type 1a
endoleaks between endografts that use IF (Gore Excluder) and SF (Cook Zenith) fixation for patients with short aortic
necks undergoing EVAR. (J Vasc Surg 2012;55:1242-6.)
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tThe era of endovascular therapy has revolutionized the
approach to patients with vascular aneurysms. Advances
have been very rapid in the treatment of aortic aneurysms.
Since the advent of endovascular stent grafts, select patients
have been treated via this less invasive technique with
improved mortality and morbidity. The first stent grafts
were large and often unwieldy, a fact that limited their
usefulness.1 As newer generations of stent grafts were de-
veloped, they were used in increasing numbers of patients
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1242ith wide anatomic variation. These technologic improve-
ents, coupled with the ever-increasing imaging capabili-
ies of most hospitals, have led to a significant increase in
he number of stent grafts placed for abdominal aortic
neurysm (AAA) disease in the United States over the last 5
ears.2
Currently, the majority of patients with AAA disease
ave neck anatomy that is suitable for endovascular therapy.
atients who have a proximal aortic neck length 15 mm,
eck diameter 26 mm, circumferential neck thrombus,
everse taper anatomy, and/or neck angulation 60 de-
rees are considered to have a hostile neck which is poorly
uited for endograft placement.3,4 At the University of
ittsburgh, approximately 80% of patients evaluated are
ligible for endovascular aneurysm repair (EVAR), and the
ast majority of those who cannot undergo endografting
re due to hostile neck anatomy.
As the endovascular experience of physicians grew, the
oundaries of the “instructions for use” (IFU) provided by
he device manufacturers have been expanded by high-
olume physicians to include patients exhibiting many of
p
p
r
i
t
c
g
E
e
s
t
c
m
1
f
2
i
(
C
p
u
s
p
t
a
t
t
p
C
d
t
s
a
t
a
w
a
R
s
p
a
y
d
f
1
d
T
y
8
S
s
l
JOURNAL OF VASCULAR SURGERY
Volume 55, Number 5 Hager et al 1243the above so-called “hostile neck” properties. Numerous
studies have shown that these limits may be pushed, espe-
cially if only one of the hostile neck variables is present.5-9 It
seems that as the use of stent grafts becomes more ubiqui-
tous throughout the United States, these boundaries will
likely be pushed even further. A recent review by Schanzer
et al10 revealed that 58% of the EVARS being performed in
the United States are being done outside of the device-
specific IFUs.
This current study examined a subset of patients with
AAAs with short straight aortic necks (1.5 cm) relative to
the performance of two different types of endografts with
different proximal fixation systems. There has been much
controversy in the past regarding the need and efficacy of
the fixation in the short- and long-term performance of
endografts. In 2011, however, most physicians believe
some type of fixation is required for accurate placement and
durability of endografts. The literature is fairly clear that,
when specific IFU guidelines are followed, most endografts
perform extremely well as demonstrated by the excellent
5-year performance records of the currently available de-
vices, as well as the long-term results of randomized con-
trolled trials like the EVAR-1 and Dutch Randomized
Endovascular Aneurysm Management (DREAM) tri-
als.11-14However, becausemany of the patients in 2011 are
being treated outside of the IFU, we sought to evaluate a
subset of this large group relative to two different philoso-
phies of endograft fixation. The goal of this study was to
evaluate two different endograft systems, the Gore Ex-
cluder (W. L. Gore, Flagstaff, Ariz) which uses infrarenal
fixation (IF), and the Cook Zenith (Cook, Bloomington,
Ind) which uses suprarenal fixation (SF). We sought to
examine whether the actual site of the fixation (infrarenal vs
suprarenal) is a significant factor in determining short- and
long-term outcome for patients undergoing EVAR with a
specified hostile neck condition (length 1.5 cm).
METHODS
All patients who underwent EVARs between the years
2002 and 2009 at a single institution were reviewed retro-
spectively from a prospectively maintained hospital and
Division of Vascular Surgery database. The study was ap-
proved for review by the local institutional review board.
Patients were selected for the study based on the presence
of a proximal aortic neck 1.5 cm, which was outside the
IFU for the endograft systems reviewed. All of these pa-
tients were considered to be high risk for direct open AAA
repair based on the presence of one of the following criteria:
reversible ischemia on stress thallium, ejection fraction
20%, or severe chronic obstructive pulmonary disease
(defined as forced expiratory volume in 1 second less than
50% of predicted). Patients were excluded if the neck
angulation was 60 degrees and had a reverse taper 5
mm. This exclusion allowed for us to analyze the patients
with an isolated short neck as a single variable. Anatomic
inclusion was based on preoperative computed tomogra-
phy (CT) scans done in an “in-house” imaging system with
3D reconstructions and direct neck measurements. The (reoperative or intraoperative angiography and detailed
reoperative clinical records were reviewed by three sepa-
ate authors (E.S.H., S.C.P., and R.Y.R.) to determine
nfrarenal neck length. All three reviewers had to agree on
he anatomic characteristics for inclusion. Morphology in-
lusive of a short proximal neck was stratified into two
roups, those who underwent EVAR with IF with the
xcluder or SF with the Zenith device. The choice of the
ndograft was based on physician preference at the time of
urgery. The endografts were deployed with standard con-
rolled deployment techniques. One patient in the Ex-
luder group had wires placed in the renal arteries to
aximize the available neck. The grafts were oversized by
0% to 15% as compared to the neck.
Hospital records and outpatient charts were reviewed
or comorbidity data outcomes after treatment. There were
1 patients who were excluded from the study based on an
ncomplete data chart (n 15) or lack of follow-up1 year
n 6). The patients underwent specific 1.5-mm cut spiral
T scans preoperatively, then at 1 month and 1 year
ostoperatively. If the 1-year postimplant CT scan was
nremarkable, the patients were transitioned to duplex scan
urveillance thereafter. The duplex scan evaluation of the
roximal neck allowed us to examine the relative position of
he endograft in relation to the renal arteries. If there was
ny suspicion for endoleak or graft migration, a computed
omographic angiography was obtained.
The primary end point at 1- and 2-year follow-up for
he study was freedom from endoleaks. Secondary end
oints were graft migration of5mm and sac stabilization.
learly, there are other differences between the two en-
ograft systems studied but these parameters were selected
o study only the effectiveness of the proximal fixation
ystem. The group’s demographics and comorbidities were
lso compared. The statistical analysis was performed using
he t-test for comparison of continuous variables and 2
nalysis for nominal data by a statistician. A P value of .05
as defined as significant. Freedom from endoleaks was
nalyzed using a life table.
ESULTS
The study identified 84 of 1379 patients with short
traight proximal aortic necks. The majority of these study
atients were treated after the construction of fixed C-arm
ngiography suites in the operating room approximately 8
ears ago. Sixty of these patients were treated with IF
evices and 24 were treated with SF devices. The average
ollow-up period was 18.6 months for the IF group and
8.5 months for the SF group. Comparison of patient
emographics and aneurysm morphology can be seen in
able I. There were no significant differences in age (76.6
ears IF vs 74.8 years SF; P .32), gender (IF 66.7% vs SF
8% men; P .053), length of stay (2.2 days IF vs 1.9 days
F; P  .39), or comorbidities. The two groups also had
imilar aneurysm morphology in terms of proximal neck
ength (1.19 cm IF vs 1.14 cm SF; P  .59) and AAA size
5.8 cm IF vs 5.9 cm SF; P  .48).
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the two groups. The number of patients with type 1 en-
doleaks identified on completion angiogram was 11
(18.3%) in the IF group and three (12.5%) in the SF group
(P  .16; Fig). All type 1 endoleaks in the IF group were
treated with covered extension cuffs (n  10) or simple
aortic ballooning (n  1). The endoleaks in the SF group
were treated with either additional ballooning (n  1) or
the addition of Palmaz (Cordis Corp, Johnson and John-
son, Warren, NJ) stents (n 2). Aside from the suprarenal
stents in the Zenith device, there were no additional stents
placed above the renal arteries. No additional “chimney”
techniques were required in these patients.
Imaging at the first follow-up appointment (mean
follow-up, 34 days) found five (8.3%) new type 1 endoleaks
in the IF group and one (4.2%) in the SF group (P  .44).
There were no type 1 endoleaks present at the end of the
surgical procedure and, therefore, it was concluded that
these were new endoleaks. There was one patient with a
type 1a endoleak found at 1 month who had a type 1a
endoleak found on angiogram at the time of the original
surgery which was successfully ballooned. All patients with
Table I. Patient demographics, comorbidities, and aneury
Infrarenal fixation
Age 76.6
Female gender 20
Diabetes 9 (15%)
Hypertension 54 (90%)
COPD 16 (28%)
Chronic renal insufficiency 3 (5%)
Coronary artery disease 27 (45%)
Mean proximal aortic neck length 1.2 cm (0.7-1.4
Mean aneurysm diameter 5.8 cm (3.4a-8.0
COPD, Chronic obstructive pulmonary disease.
aIndicates saccular aneurysm.
Table II. Primary outcomes between groups
Infrar
(
Type 1 endoleaks on completion angiogram 11
Intervened upon 11
Type 1 endoleaks at 30-day follow-up 5
Intervened upon 1
Type 1 endoleaks at 1-year follow-upa 1
Type 2 endoleaks at 30-day follow-up 5
Intervened upon 3
Type 2 endoleaks at 1-year follow-up 2
Intervened upon
Type 2 endoleaks at 2-year follow-up 2
Intervened upon
Mean change in sac size per year 0
Graft migration
Aneurysm-related death
NS, Not significant.
P values  .05 are considered significant.
aIndicates patient was lost to follow-up after 1 year.this problem were offered either chimney revision with cuff txtension or open conversion, although they were at high
isk due to underlying medical conditions. The one patient
n the SF groupwith the type 1 endoleak and four of the five
atients in the IF group with endoleaks had stable aneu-
ysm sac sizes and elected to be observed without interven-
orphology according to fixation type
60) Suprarenal fixation (n  24) P value
74.8 .32
3 .50
3 (13%) .54
20 (83%) .31
4 (17%) .25
0 .36
11 (46%) .95
1.1 cm (0.5-1.4 cm) .48
4.9 cm (4.8-8.2 cm) .59
fixation
0)
Suprarenal fixation
(n  24) P value
3%) 3 (12.5%) NS
%) 3 (100%)
%) 1 (4.2%) NS
) 0
%)a 1 (4.2%)a NS
%) 1 (4.2%) NS
) 0
%) 1 (4.2%) NS
0
%) 1 (4.2%) NS
0
m/y 0.26 cm/y NS
0
0
ig. Life table showing freedom from type 1 endoleaks. IF, Infra-
enal fixation; SF, suprarenal fixation.sm m
(n 
cm)
cm)enal
n  6
(18.
(100
(8.3
(20%
(1.6
(8.3
(60%
(3.2
0
(3.2
0
.24 c
0
0ion. The fifth patient in the IF group did have sac enlarge-
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Three of the remaining four patients in the IF group had
resolution of the endoleak at the time of the next CT scan.
There was persistence of the type 1 endoleak in the last IF
patient as well as the SF patient with no increase in sac size
at 1 year. Both of these patients were lost to follow-up after
the 1-year period. Both the IF and SF groups demonstrated
equal mean regression of the aneurysm sac over the 2-year
period (0.24 cm/year IF vs 0.26 cm/year SF; P  not
significant [NS]). Five patients in the IF group demon-
strated sac enlargement from type 2 endoleaks. Three pa-
tients had substantial sac growth (average 1 cm) and re-
quired coiling of the offending lumbar or inferior
mesenteric artery. The two patients not treated had a small
amount of sac enlargement noted on 1-month follow-up
but did not have any further enlargement on later imaging.
There was one patient in the SF group that had a small
degree of sac enlargement (0.3 cm at 1-month follow-up)
from a type 2 endoleak which was managed conservatively.
There were no endograft migrations or aneurysm-related
deaths over the follow-up period.
DISCUSSION
Endovascular repair of AAAs has become common-
place across the world. Interestingly, only 42% of patients
meet the strictest device-specific IFU criteria and can be
treated via the endovascular approach.10 The patients that
fall outside the IFU are still considered for treatment by
most practitioners, especially if only one anatomic variable
that does not meet criteria is present and the patient’s
comorbidities preclude open repair. In fact, a recent report
showed that almost 40% of EVARS done today are per-
formed outside of the IFU.15
There have been many techniques described that at-
tempt to safely treat short proximal aortic necks via endo-
vascular means. In 2003, Greenberg et al16 discussed using
proximal Palmaz stents to increase the radial force of the
aortic graft as well as increase wall apposition. They also used
balloon-expandable stents (chimney technique) placed
within the renal artery to effectively raise the level of the
renal orifice. They concluded that challenging aortic anat-
omy was not a contraindication to endovascular repair in
high-risk candidates, and these techniques could aid in the
approach to the short aortic neck. Other studies have
shown that short aortic proximal necks can be treated
successfully even without these techniques.5-9,17
In 2006, an analysis of the 3499 patients in the Euro-
pean Collaborators on Stent/Graft Techniques for Aortic
Aneurysm Repair (EUROSTAR) registry was performed to
help predict outcomes after EVAR based on the length of
the proximal aortic neck. The patients were divided into
three groups; group A had a proximal aortic neck15 mm
(reference group, n  2822), group B had a neck of 11 to
15 mm (n  485), and group C had a proximal neck 10
mm (n  192). Univariate and multivariate analyses were
performed and found that there was a significantly higher
incidence of type 1 endoleaks at 1 month in group C as
compared to group A (10.9% vs 2.6%) and within 48 ponths (11.3% vs 3.4%).17 These outcomes were later
irrored by Abu Rahma et al9 who examined 238 patients
nd subdivided them into three groups; patients with prox-
mal necks15mm (L1; n 195), patients who had necks
0 to 14 mm (L2; n  24), and patients with 10 mm
ecks (L3; n 17). They found that the rates of early type
a endoleaks occurred in 12%, 42%, and 53% in groups L1,
2, L3, respectively (P  .001). They also noted that the
eed for proximal aortic cuffs needed to achieve adequate
eal was 10%, 38%, and 47%, respectively (P  .0001).
here was no statistically significant difference in the rate of
eintervention or sac regression. They concluded that
VAR can be performed in patients with extremely short
ortic necks, although the rate of proximal endoleaks is
ignificantly higher and requires more frequent proximal
xtension cuffs to achieve adequate seal.
Among vascular surgeons, it has been long believed
hat the use of SF is superior to IF in the treatment of
atients with short proximal aortic necks. In theory, the
ctive fixation (barbs) would be in the healthy segment of
ormal aorta and should allow adequate apposition of graft
aterial and aortic wall just below the renal arteries. In
001, Stanley et al18 analyzed the Zenith Endovascular
raft Research Database on 238 patients treated with the
enith (SF) device. They found a 56% type I endoleak rate
n patients with short aortic necks (10 mm) and con-
luded that patients with short aortic necks should not be
reated with the Zenith device. Five-year outcome data
omparing the Excluder and the Zenith devices are com-
arable when used within the IFU because the sealing zone
engths were essentially the same for both studies. There
as not been any published data related to the treatment of
hort-necked AAAs using an IF device such as the Excluder
ntil this study. With the introduction of the C3 Gore
ystem, placement of the device may be more precise due to
he ability to recapture poorly placed endografts and may
heoretically limit the use of extension cuffs.
These data clearly show that when other hostile param-
ters do not exist, short straight-necked AAAs can be
reated safely with excellent midterm results with both SF
nd IF devices. We have shown that, despite comparable
roup demographics, comorbidities, and aneurysm mor-
hology, there is no statistically significant difference be-
ween groups in terms of number of reinterventions, graft
igration, graft-related deaths, or regression of the sac of
he aneurysm.
Although the two study endograft systems differ in
echanical and structural characteristics in addition to the
xation system, the specific aim of the study was to only
valuate the performance of the proximal fixation and the
bility of the endograft system to maintain its position and
eal. It is not surprising that there were no graft migrations
oted in this study group as the active fixation typically
revents this. In theory, the endoleaks can be attributed, in
he absence of migration, to aortic neck remodeling and
ilation from the endograft itself.
Initial type 1 endoleaks were attributed to suboptimal
roximal placement of the endograft. These were treated in
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group), ballooning, or bare metal balloon-expandable
stents (in the SF group). We did note that there seemed to
be a slight trend toward early (30-day) occurrence of type 1
endoleaks in the IF group. Due to the small number of
patients in the study, it is difficult to evaluate fully what the
true clinical sequelae of such findings are. We felt that the
major limitations of our study were the small number of
patients in this dataset, the fact that the results can only be
applied to endograft systems that use proximal fixation (ie,
the Gore Excluder and Cook Zenith systems), and that
there was not a longer follow-up period for most patients.
This said, the concept of aggressively treating short necks
only became possible after the introduction of higher-
quality imaging and fixed C-arm endovascular systems.
Another relative limitation was the nonrandomized nature
of the study in terms of the surgeon’s device preference.
The trend at our institution was to use the Zenith device in
the earlier years of this study period with the gradual move
to the Excluder during the latter part of the study.
CONCLUSIONS
In our study, we noted no significant differences in
endograft migration or in the incidence of early and late
type 1a endoleaks between endografts that use IF (Gore
Excluder) and SF (Cook Zenith) for patients with short,
straight aortic necks undergoing EVAR. This is not appli-
cable to all endograft systems, however, and further studies
should be carried out to determine applicability of these
devices in short aortic necks.
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